Indaptus Therapeutics Inc... (INDP)
0.89
-0.01 (-1.11%)
At close: Jan 15, 2025, 3:44 PM
0.87
-2.59%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -15.42M | -14.32M | -7.71M | -3.58M | -47.60M | -43.54M | -28.91M | -13.36M | -7.18M | -5.69M | -5.09M | -5.18M | -7.58M | -5.42M | -3.94M | -5.36M |
| Depreciation & Amortization | 1.28K | 1.78K | 1.40K | 852.00 | 854.00K | 859.00K | 829.00K | 701.00K | 745.90K | 584.82K | 602.85K | 555.43K | 340.68K | 367.33K | 305.53K | 302.32K |
| Stock-Based Compensation | 2.97M | 2.96M | 1.51M | 139.96K | 124.37K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 162.45K | -425.59K | -854.15K | 4.81K | 295.00K | 28.00K | n/a | 415.00K | 413.88K | -457.06K | 378.17K | -174.00K | 257.67K | -48.23K | 64.93K | 147.39K |
| Other Non-Cash Items | -430.99K | -134.16K | 5.75M | -3.36M | 18.97M | 6.64M | -2.57M | 1.69M | 3.75M | 405.63K | 451.03K | 613.78K | 1.38M | 1.53M | 390.32K | 1.12M |
| Deferred Income Tax | n/a | n/a | -5.75M | 3.36M | 281.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -518.07K | -1.58M | -5.09M | 118.71K | 227.00K | -642.00K | 5.09M | 392.00K | -1.67M | -48.08K | 656.04K | -488.53K | 478.73K | -785.04K | 167.28K | 157.72K |
| Operating Cash Flow | -13.41M | -13.08M | -11.29M | -3.32M | -29.05M | -39.08M | -22.13M | -12.01M | -7.93M | -4.75M | -3.38M | -4.50M | -5.38M | -4.31M | -3.08M | -3.78M |
| Capital Expenditures | n/a | -172.56K | -3.85K | n/a | -921.00K | -9.60M | -5.00M | -482.00K | -1.39M | -75.76K | -1.49M | -206.40K | -2.31M | -474.77K | -528.83K | -203.22K |
| Acquisitions | n/a | 172.56K | 451.60K | n/a | n/a | n/a | 7.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.52K |
| Purchase of Investments | -6.86M | -29.60M | n/a | n/a | n/a | n/a | n/a | n/a | -5.00M | n/a | -1.65M | -1.54M | -235.03K | -4.77M | n/a | n/a |
| Sales Maturities Of Investments | 24.00M | 13.00M | n/a | n/a | 576.00K | 298.00K | 247.00K | 5.21M | n/a | 2.80M | n/a | 218.08K | 3.71M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 172.56K | 451.60K | n/a | -2.87M | n/a | n/a | n/a | n/a | -8.67K | 21.05K | n/a | -1 | 13.13K | n/a | n/a |
| Investing Cash Flow | 17.14M | -16.43M | 447.75K | n/a | -3.21M | -9.30M | -4.75M | 4.72M | -6.39M | 2.72M | -3.12M | -1.53M | 1.17M | -5.23M | -528.83K | -188.70K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23.31K | -682.10K | 2.63M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 43.34M | n/a | 250.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 |
| Financial Cash Flow | n/a | n/a | 48.34M | 1.16M | 2.37M | 35.06M | 63.71M | n/a | 31.94M | 4.83M | 9.28M | 3.38M | 2.98M | 12.56M | 4.55M | 3.93M |
| Net Cash Flow | 3.74M | -29.51M | 37.49M | -2.16M | -29.95M | -14.15M | 36.96M | -7.28M | 17.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | -13.41M | -13.25M | -11.29M | -3.32M | -29.97M | -48.67M | -27.13M | -12.49M | -9.32M | -4.83M | -4.87M | -4.71M | -7.69M | -4.79M | -3.61M | -3.98M |